ERBB2 and breast carcinoma: Recently, the phenotypical and functional variety of breast cancer cells in primary tumors as well as in DTCs is shown for recognized prognostic factors, such as HER-2/neu [19-21], ER, PR [21] and cancer stem cell markers such as CD44, CD24 or ALDH1 [22,23].